Daily Archives:
March 21st, 2013

  • FILTER

  1. Ben Franklin Alumnus Particle Sciences Partners with Calvert Labs in Drug Services Pact

    Particle Sciences (http://www.particlesciences.com/) and Calvert Labs have formed an alliance to offer a streamlined solution aimed at expediting preclinical drug development. This partnership will alleviate formulation challenges that often delay entry into preclinical testing by aligning formulation and preclinical experts to identify the problem and provide a solution more quickly. Particle Sciences will work to develop a formulation Continue Reading…

  2. Texas Instruments Lehigh Valley

    TI LEHIGH VALLEY’s technology dramatically increases efficiency in power systems, delivering new levels of system compactness, cost, and performance. Its highly efficient power chip reduces the heat given off by power supplies and redirects that energy to the device being energized. The technology has been designed into hundreds of millions of products offered by world Continue Reading…

  3. Saladax Biomedical, Inc.

    SALADAX BIOMEDICAL, INC. is a diagnostics company that provides kits to test for drug-level adherence and dose management. The company produces MyCare™, sophisticated blood tests that quickly, accurately, and inexpensively determine systemic chemotherapy drug levels that enable oncologists to personalize dosing for optimal results in cancer patients. Saladax is one of two anchor companies at Continue Reading…

  4. Intuidex, Inc.

    INTUIDEX, Inc. develops and deploys data mining and data visualization software for large applications. The company’s software retrieves key pieces of information from narrative text, and extracts and compares the key information. Intuidex’s IxEE platform is being used by the U.S. Air Force, the Port Authority of NY-NJ, and the National Science Foundation.    

  5. Hager Bioscience, LLC

    HAGER BIOSCIENCES, LLC is a preclinical-stage drug discovery company based on innovative medicinal chemistry capabilities that provides sought-after therapeutic leads for unmet medical needs. Hager’s discovery fragment pharmacophore platform, FragPhore®, provides a competitive advantage for the efficient and rapid optimization of a drug candidate’s medicinal chemistry, improvement in pharmaceutical properties, and enhancement of intellectual property. Continue Reading…

  6. Azevan Pharmaceuticals, LLC

    AZEVAN PHARMACEUTICALS LLC develops pharmaceuticals for the treatment of central nervous system (CNS) disorders. Its focus has been on stress-related affective illness resulting in anxiety and depression, CNS disorders causing aggression, and female health issues. Its lead compound, SRX246, is in a Phase II clinical trial for treatment of Intermittent Explosive Disorder and other mood Continue Reading…